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Abstract
Background: Mortality from cardiovascular and other chronic diseases has increased in Iran. Our aim was to
estimate the effects of smoking and high systolic blood pressure (SBP), fasting plasma glucose (FPG), total
cholesterol (TC), and high body mass index (BMI) on mortality and life expectancy, nationally and subnationally,
using representative data and comparable methods.
Methods: We used data from the Non-Communicable Disease Surveillance Survey to estimate means and standard
deviations for the metabolic risk factors, nationally and by region. Lung cancer mortality was used to measure
cumulative exposure to smoking. We used data from the death registration system to estimate age-, sex-, and
disease-specific numbers of deaths in 2005, adjusted for incompleteness using demographic methods. We used
systematic reviews and meta-analyses of epidemiologic studies to obtain the effect of risk factors on disease-
specific mortality. We estimated deaths and life expectancy loss attributable to risk factors using the comparative
risk assessment framework.
Results: In 2005, high SBP was responsible for 41,000 (95% uncertainty interval: 38,000, 44,000) deaths in men and
39,000 (36,000, 42,000) deaths in women in Iran. High FPG, BMI, and TC were responsible for about one-third to
one-half of deaths attributable to SBP in men and/or women. Smoking was responsible for 9,000 deaths among
men and 2,000 among women. If SBP were reduced to optimal levels, life expectancy at birth would increase by
3.2 years (2.6, 3.9) and 4.1 years (3.2, 4.9) in men and women, respectively; the life expectancy gains ranged from
1.1 to 1.8 years for TC, BMI, and FPG. SBP was also responsible for the largest number of deaths in every region,
with age-standardized attributable mortality ranging from 257 to 333 deaths per 100,000 adults in different regions.
Discussion: Management of blood pressure through diet, lifestyle, and pharmacological interventions should be a
priority in Iran. Interventions for other metabolic risk factors and smoking can also improve population health.
Introduction
Iran has experienced unprecedented demographic changes
over the past few decades. According to the General Popu-
lation and Housing Census, the number of adults older
than 64 years of age increased from 1.2 million in 1976
(3.7% of the population) to 3.5 million in 2006 (5.5% of
the population). Chronic diseases, especially cardiovascular
diseases (CVD), have also become a more prominent
cause of death, responsible for 47% of all deaths in 1995,
compared with 27% in 1981 [1].
An important question for planning and allocating
resources is the role of metabolic and lifestyle risk factors
on mortality, especially from CVD. A previous analysis [2]
estimated the mortality effects of major risk factors in Iran
but was based on data that were not nationally representa-
tive. Further, the previous analysis estimated the effects of
systolic blood pressure (SBP), total cholesterol (TC), and
body mass index (BMI) below and above clinical thresh-
olds, even though epidemiologic studies have shown that
the association between these risk factors and CVD risk
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has not been an assessment of the incompleteness of
the vital registration system and misclassification of cause
of death, or of uncertainty of the estimated number of
deaths attributable to risk factors. Nationally and provin-
cially representative data on risk factors are now available
for 2005 from a health examination survey focused on
noncommunicable diseases, and large meta-analyses of
cohorts have provided new evidence on the effects of
these risk factors on CVD [4,5]. There are also new meth-
ods that help adjust for incompleteness of mortality regis-
tration [6].
We used these advances in data and methods to esti-
mate the mortality effects of metabolic and lifestyle risk
factors at the national level. To understand how risk fac-
tors may affect mortality in different parts of Iran, we
extended the analysis to groups of provinces defined by
geography and socioeconomic status. We also quantified
the uncertainty in our results.
Methods
We conducted a population-level comparative risk assess-
ment (CRA) for five modifiable risk factors. Based on data
availability on exposure and effect size, the risk factors in
the analysis were smoking and four metabolic risks: BMI,
SBP, fasting plasma glucose (FPG), and TC. The CRA ana-
lysis estimates the number of deaths that would have been
prevented if past and current exposure to risk factors were
reduced to a hypothetical alternative distribution. The
inputs to the analysis are: [1] the current distribution of
exposure to the risk factor in the population, [2] the etio-
logical effect of the risk factor on disease-specific mortal-
ity, [3] an alternative exposure distribution, and [4] the
total number of disease-specific deaths in the population.
Analyses were done separately by sex and by the following
age groups: 30-44, 45-59, 60-69, 70-79, and ≥ 80 years.
Exposure to risk factors
Means and standard deviations (SD) for the metabolic
risk factors were estimated from the 2005 Non-Commu-
nicable Disease Surveillance Survey (NCDSS), which is
representative at the national and provincial level, and
uses a multistage systematic clustered sampling applied
to rural and urban areas of all provinces [7,8]; the survey
was implemented simultaneously in all provinces
between December 2004 and February 2005 and included
89,400 individuals aged 15 to 64 years. The survey
included a questionnaire and physical and laboratory
measurements of weight, height, and systolic and diasto-
lic blood pressure for all participants and FPG and lipids
for 50,202 participants aged 25 to 64 years old. SBP was
measured using a standard mercury sphygmomanometer,
with each participant measured three times in sitting
position; weight was measured using a calibrated beam
scale; and plasma was separated from the fasting blood
sample and analyzed on the same day.
We imputed the mean and SD of metabolic risks in age
groups above 65 years of age using data from 47 health
examination surveys from other countries. Specifically,
we estimated the linear slope between the ages of 30 and
64 by province for the NCDSS and for data from 47
health examination surveys from other countries with
data for ages 65 years and older. We divided the slopes
between 30 and 64 years from the latter surveys into ter-
tiles; for each tertile, we estimated the average slope < 65
years in data pooled from all surveys, adjusting for inter-
survey differences (i.e., survey-specific intercepts). For
each Iranian province, the slope of each risk factor by age
for ages 65 and older was taken from the tertile to which
its slope below age 65 years belonged. We estimated the
SD of the distribution for each risk factor for age groups
above 65 years using the SD-mean relationship across all
47 health examination surveys. Following previous ana-
lyses [9-11] we used lung cancer mortality to measure
cumulative population exposure to smoking.
One-off measurement of metabolic risk factors in health
examination surveys overestimates the SD of the “usual”
population exposure distribution, due to within-person
variation. We estimated the usual population SD of SBP,
FPG, and TC by multiplying the SD of the NCDSS sample
by the dilution ratio from studies that had multiple expo-
sure measurements [12-14]. We did not adjust the SD of
BMI for within-person variations in body weight, because
studies with multiple BMI measurements have not found
evidence for substantial within-person variability in BMI
[15].
Etiologic effects of risk factors
For each risk factor-disease pair with convincing evidence
of causality, relative risks (RRs) were derived from recent
reviews of epidemiologic studies, summarized in the Uni-
ted States CRA study [10]. Previous work has shown that
after accounting for study design and methodological dif-
ferences, etiological effect sizes are consistent across dif-
ferent populations [16], and hence, in the absence of
reliable evidence for etiological effects from Iran, large
meta-analyses of international cohorts are the best source
of etiological effect sizes.
Disease-specific mortality
Population data by age, sex, and province were from the
1996 and 2006 national censuses. Deaths by age, sex, pro-
vince, and underlying cause of death were from the mor-
tality registration system, which covers all 30 provinces
but excludes Tehran city, where 13.5% of the population
lives [17]. We used data from Tehran’s central cemetery
for Tehran city. To examine and correct the incomplete-
ness of death registration, we used death distribution
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Generalized Growth Balance (GGB), Synthetic Extinct
Generations (SEG), and a hybrid of the two methods
(GGBSEG). We chose SEG because it gave the highest
correlation between the estimated adult and child mor-
tality completeness (rSEG = 0.16, rGGB = 0.04, rGGBSEG =
0.035). We estimated child mortality and completeness of
child death registration by comparing under-5 mortality
estimates from the death registration system to estimates
generated from the 2001 Demographic and Health Sur-
vey (DHS) and the 2006 census, an approach that has
been extensively used in the literature [19].
Of the 262,000 deaths in the Iranian death registration
system in 2005, about 19,000 deaths (7.4%) had an
unknown cause. We used data from a study in 2005 that
reviewed hospital medical records by trained physicians
[20] to estimate the underlying medical causes for these
deaths. We applied multinomial logistic regression to data
from the above study and used the regression coefficients
to estimate the proportions of different diseases as under-
lying causes for these deaths, as a function of the dece-
dent’s age, sex, and province of residence. Age was
missing for 0.7% and sex for 0.4% of deaths. We used mul-
tiple imputation using Amelia software [21] to impute
missing age and sex values.
Mortality effects of risk factors
For each risk factor and for each disease causally linked
with its exposure, we computed the proportional reduc-
tion in disease-specific deaths that would occur if risk
factor exposure had been reduced to an alternative level,
known as the population-attributable fraction (PAF). For
risks measured continuously (SBP, BMI, TC, and FPG),
we computed PAFs using equation 1:
PAF =
m 
x=0
RR(x)P(x)dx −
m 
x=0
RR(x)P (x)dx
m 
x=0
RR(x)P(x)dx
(1)
where x is the risk factor exposure level, P(x)i st h e
actual exposure distribution, P’(x) is the alternative expo-
sure distribution, RR(x) is the relative risk of mortality at
exposure level x for that specific disease, and m is the
maximum exposure level.
We used the theoretical minimum risk exposure distri-
bution (TMRED) as the alternative exposure distribution
to measure the mortality effects of all nonoptimal levels
of exposure consistently and comparably across risk fac-
tors [10,22]. Based on a previous review of epidemiologi-
cal evidence, the mean (g ± SD) of the TMREDs was
chosen to be 21 (± 1) kg/m
2 for BMI, 115 (± 6) mmHg
for SBP, 3.8 (± 0.6) mmol/L for TC, and 4.9 (± 0.3)
mmol/L for FPG.
We calculated deaths, mortality rates, and loss of life
expectancy attributable to each risk factor. The mortality
rates were age standardized using the national Iranian
population in 2005 as the reference population. Life
expectancies were calculated using standard life-table
methods and accounted for the effects of death rates in
older ages using the Coale-Guo method [23,24]. Life
expectancy under the TMRED distribution was calcu-
lated by reducing mortality rates in each life table age
group by the proportion attributable to risk factors and
recalculating the life tables.
Uncertainty in estimates
We quantified the uncertainty of the number of deaths
attributable to each risk factor, accounting for uncer-
tainty due to sampling variability of the exposure data
and those of other input parameters. We used a simula-
tion approach to combine the uncertainties of exposure
distributions, RRs, and disease-specific mortality in each
age-sex group. Under 65 years of age, in each iteration,
we used one randomly-drawn exposure mean and SD
from their distributions (normal and Chi-square distri-
butions, respectively). Above 65 years, the uncertainty of
the coefficients of the age-association regression model
was also added using repeated draws from their distri-
butions. RRs for each disease were drawn from a log-
normal distribution, independently from exposure
draws. Each set of exposure and disease-specific RR
draws was used to calculate one PAF, separately by age
group and sex. We expressed the uncertainty related to
incompleteness of death registration as variance of the
estimated level of completeness, assuming a SD of 20%
of the estimated completeness [6]. We used 1,000 draws
for each of the above parameters in repeated calcula-
tions, and reported 95% uncertainty intervals (UIs)
based on the resulting distributions of 1,000 estimated
attributable deaths. The above analysis does not include
the uncertainty associated with the basic assumptions
regarding the extrapolation of age patterns and RRs
across populations.
Subnational analysis
We conducted analyses by province and also by four
regions. The regions were defined based on a combina-
tion of geography and socioeconomic status (SES). SES
was measured using an index constructed from variables
from the 2006 census, including years of schooling,
employment rates, and family assets [25]. We combined
these characteristics using principal component analysis
and used these principal components in combination
w i t hg e o g r a p h yt od i v i d et h ec o u n t r yi n t of o u rl a r g e
regions (Figure 1). The Southeast region has the lowest
SES and the Central region the highest.
All analyses were done using R version 2.11.1.
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Mortality and life expectancy in Iran
After correcting for incompleteness, there were an esti-
mated 352,000 deaths in Iran in 2005. Of these, 277,000
deaths occurred in adults 30 years of age or older (59%
in men). 53% of deaths above age 30 were due to CVD,
including 26% from ischemic heart disease (IHD), 13%
from stroke, 4% from hypertensive diseases, and 10%
from other CVD. Life expectancy at birth in Iran was
70.0 years for men, ranging from 68.2 years in the
Western region to 70.5 years in the Southeast; for
women, it was 74.6 years and ranged from 73.5 years in
the Western region to 75.6 years in the Southeast.
Risk factor exposure
Estimated mean SBP was similar between men (126.7
mmHg; 95% UI: 126.5, 127.9) and women (126.2 mmHg;
126.0, 126.5) (Figure 2). Women had higher BMI (27.5 kg/
m
2; 27.5, 27.6), FPG (5.60 mmol/L; 5.56, 5.64), and TC
(5.37 mmol/L; 5.35, 5.38) than men, while men had a
higher prevalence of smoking (34.7%; 34.0, 35.4) than
women (6.7%; 6.4, 7.0) at the national level (Figure 2).
Age-standardized mean BMI and TC for both sexes and
SBP for women in Iran were higher than the mean global
level [26-28].
The differences across regions in SBP were not statisti-
cally significant, although SBP tended to be lowest in the
Central region and highest in the North-Northeast region.
The Central region, with the highest SES, had the highest
FPG (5.61 mmol/L; 5.53, 5.68). The Southeast region, with
the lowest SES, had the highest prevalence of smoking
(36.1% for men and 16.4% for women) but the lowest BMI
(23.1 kg/m
2 for men and 24.7 kg/m
2 for women).
Mortality effects of risk factors
SBP was the leading risk factor for cardiovascular mortality,
causing 41,000 deaths (38,000, 44,000) among men and
39,000 deaths (36,000, 42,000) among women (Table 1). If
SBP is lowered to its optimal distribution, life expectancy at
birth would increase by 3.2 years (2.6, 3.9) in men and 4.1
years (3.2, 4.9) in women (Figure 3). The age-standardized
mortality attributable to SBP ranged from 257 to 333
Figure 1 Geographic regions used in the analysis.
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Page 4 of 11deaths per 100,000 adults among men and women in differ-
ent regions. TC and FPG had the second-largest effect on
mortality among men, each causing 17,000 to 18,000
deaths, less than half of the deaths due to increased SBP.
Among women, SBP was followed by FPG and BMI, each
responsible for about 17,000 deaths. Life expectancy effects
for FPG, BMI, and TC ranged from 1.1 to 1.8 years in both
sexes. Smoking had the smallest mortality effects for both
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Figure 2 Prevalence of smoking and mean levels of other risk factors in 2005, by region and sex. All figures are age-standardized to the
2005 national population.
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Page 5 of 11Table 1 Number of deaths attributable to each risk factor in 2005, by region and sex
BMI FPG SBP TC Smoking
Male Female Male Female Male Female Male Female Male Female
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
Mean
(95% UI)
National 13000 (11000,
15000)
17000 (14000,
20000)
17000 (14000,
20000)
17000 (14000,
20000)
41000 (38000,
44000)
39000 (36000,
42000)
18000 (16000,
20000)
16000 (14000,
18000
9000 (8600,
9400)
2000 (1900,
2100)
Southeast 700 (600, 800) 700 (600, 800) 1400 (1100,
1700)
1100 (900, 1300) 3200 (3100,
3300)
2800 (2700,
2900)
1500 (1400,
1600)
1200 (1100,
1300)
500 (490, 510) 200 (190, 210)
North-
Northeast
3200 (2700,
3700)
4400 (3700,
5100)
3200 (2600,
3800)
3900 (3200,
4600)
8800 (8400,
9200)
9100 (8700,
9500)
4200 (3900,
4500)
3800 (3500,
4100)
1600 (1560,
1640)
500 (480, 520)
West 5400 (4600,
6200)
7100 (5900,
8300)
6500 (5300,
7700)
6300 (5100,
7500)
16800 (16300,
17300)
15100 (14700,
15500)
7000 (6700,
7300)
5800 (5500,
6100)
3900 (3800,
4000)
800 (780, 820)
Central 3700 (3200,
4200)
5300 (4300,
6300)
5300 (4400,
6200)
5300 (4300,
6300)
12600 (12100,
13100)
11900 (11400,
12400)
5700 (5300,
6100)
4600 (4200,
5000)
2600 (2500,
2700)
900 (870, 930)
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1men (9,000 deaths, about one-fifth of the number attributa-
ble to SBP) and women (2,000 deaths, < 5% of the number
attributable to SBP).
The PAFs for the effects of all four metabolic risk fac-
tors on IHD and stroke were larger in women than
men, due to higher exposure. However, deaths attributa-
ble to these risks were larger among men, due to the
larger number of CVD deaths. Reducing these risk fac-
tors to their optimal levels would have led to gains in
life expectancy that were nonsignificantly larger in
women, possibly due to larger PAFs and differences in
distributions of deaths by age and competing causes.
High SBP was the leading cause of mortality in all
regions. Age-standardized mortality rates attributable to
SBP were highest in the North-Northeast and Western
regions, ranging from 310 to 330 deaths per 100,000 adults
for both sexes; they were lowest in the Southeast in both
sexes, because the age-standardized cause-specific mortal-
ity rate from CVD is lowest in this region (Figure 4). The
North-Northeast and Western regions also had the largest
PAF for the effects of SBP on IHD and stroke, ranging
from 45% to 63% (detailed results not shown). However,
the effects of SBP on life expectancy were largest in the
Southeast (3.8 years gained in men and 5.5 years gained in
women), possibly because CVD deaths occur in younger
ages in this region.
Although the Southeast had the highest reported pre-
valence of current smoking, age-standardized mortality
attributable to smoking, calculated using lung cancer
mortality as indicator of cumulative exposure, was lar-
gest in the Central region among women (21 deaths per
100,000; 20, 22) and the Western region among men
(75 deaths per 100,000; 74, 76). The differences may be
due to longer history of smoking in the Central and
Western regions, as well as higher age-specific mortality
rates from diseases caused by smoking.
The highest provincial age-standardized mortality rate
attributable to SBP was about 70% larger than the lowest
one (the difference was about 150 deaths per 100,000). For
BMI, FPG, and TC, the highest attributable mortality rate
was 1.2 to 2.2 times that of the lowest. For smoking, the
highest attributable mortality rate was 12 times higher in
women and 32 times higher in men than that of the
lowest.
Figure 3 Effects of each risk factor on life expectancy at birth in 2005, by region and sex.
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Our results indicate that high SBP had the single largest
mortality impact nationally, as well as in every province
and region in Iran, causing an estimated 80,000 annual
deaths in 2005. If SBP were reduced to optimal levels,
life expectancy at birth would increase by 3.2 years (2.6,
3.9) and 4.1 years (3.2, 4.9) in men and women, respec-
t i v e l y .H i g hF P G ,B M I ,a n dT Cw e r er e s p o n s i b l ef o r
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Figure 4 Age-standardized mortality rates attributable to each risk factor in 2005, by region and sex.
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Page 8 of 11about one-third to one-half of deaths attributable to SBP
in men and/or women. The effects of smoking on life
expectancy at the national and subnational levels were
less than one year, primarily because the rise in smoking
is a more recent phenomenon in Iran than in Western
countries and even East Asia.
Our analysis extends the emerging body of research on
national and subnational CRA analyses [10,29-31]. The
strengths of our study include combining national and
subnational analyses using representative data, using
effect sizes from large meta-analyses, estimating incom-
pleteness of death registration using rigorous demo-
graphic methods, redistributing deaths with unknown
causes, and quantification of uncertainty.
A key limitation of our study is that we did not have
data on dietary factors, physical activity, alcohol and illicit
drug use, or other metabolic risk factors, e.g., lipopro-
teins. Moreover, our exposure data did not include peo-
ple 65 years of age and older, requiring extrapolation and
leading to additional modeling assumptions and uncer-
tainty beyond the quantified statistical uncertainty. In
2005, 5.5% of Iran’s population and 49% of deaths were
in those aged 65 years and older. We used RRs in specific
cohorts and their meta-analyses. While this extrapolation
adds a source of unquantifiable uncertainty, population-
level estimation is indispensable to inform policymaking.
More importantly, there is empirical evidence to support
the proposition that proportional effects are similar
across populations, e.g., Western and Asian populations
[12,32,33]. Despite these limitations, our analysis, and
those of others [10,29-31] demonstrate the value of
nationally and subnationally representative data on risk
factors for policy formulation and planning.
Our results have a number of implications for national
and subnational health policies and programs in Iran, as
well as for other middle-income countries. First, our analy-
sis highlights the importance and the need for periodic
risk factor surveillance studies to measure trends, which
may be used for evaluating implemented policies. Recent
comprehensive systematic reviews of metabolic risk factors
showed that developing countries in Latin America and
the Caribbean, Middle East and North Africa, Central and
Southeast Asia, and sub-Saharan Africa had limited data,
especially longitudinal data, on metabolic risk factors
[26-28,34]. Our study supports the value of population-
based surveillance for not only comparative cross-country
analysis, but also for national and subnational priority set-
ting. The demographic and epidemiologic transitions in
Iran and other middle-income countries, which inevitably
lead to aging of the population, make it essential to
increase the participation of the elderly in health examina-
tion surveys. Future surveys should also include important
dietary and lifestyle risk factors that were not included in
our analysis.
Beyond risk factor surveillance, interventions are
needed to address metabolic risk factors. Many coun-
tries have successfully lowered blood pressure levels in
the past three decades; for example, blood pressure
decreased by about 2.0 to 4.0 mmHg per decade in wes-
tern European countries and Australia [28]. Although
Iran has a hypertension control program, it only focuses
on high-risk patients [35]. Our results indicate that a
greater emphasis on reducing blood pressure at the
population level through improved detection and better
treatment in primary care is needed to reduce CVD
mortality. Further, population-level analyses of trends
and meta-analyses of randomized trials have shown that
lowering salt intake can lower blood pressure [36,37].
Since the traditional Iranian diet is wheat-based [38],
reducing salt in bread through regulation or large-scale
media campaigns may help lower blood pressure at the
population level.
There is currently no comprehensive program to con-
trol obesity in Iran, either in the primary health care
system or through lifestyle and dietary interventions,
although diabetes management has been integrated in
the primary care system in rural areas [39]. Community-
based interventions such as family-oriented advice on
healthy eating and physical activity by a dietitian have
been shown to increase physical activity, improve dietary
habits, and reduce weight gain [40]. Integrating obesity
and diabetes prevention and control programs in the
primary health care system and using community health
workers might help increase compliance and reduce
these risk factors, as has been done for diabetes in rural
areas [39]. Identifying, implementing, and evaluating
such interventions are particularly important in the light
of rising overweight and obesity in Iran and worldwide
[27], which would inevitably lead to an increase in dia-
betes and hypertension unless population-based inter-
ventions are implemented.
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